Why the study?
Does instrumental treatment (baroreceptor stimulation or renal sympathetic denervation) reduce blood pressure in patients with resistant hypertension?
Does instrumental treatment (baroreceptor stimulation or renal sympathetic denervation) reduce blood pressure in patients with resistant hypertension?
Device therapies such as carotid baroreceptor stimulation and renal sympathetic denervation are being tested as treatments for resistant hypertension.
Device therapies remain investigational for resistant hypertension; leaves open efficacy pending definitive RCTs.
It is well known that hypertension is an independent cardiovascular risk factor. Treatment of hypertension frequently includes administration of three or more drugs. Resistant hypertension is defined when blood pressure remains above target value despite full doses (the patient's maximum tolerated dose) of antihypertensive medication consisting of at least three different classes of drugs including a diuretic. Pharmacological treatment of hypertension is often unsuccessful despite the increasing number of drug combinations. Uncontrolled hypertension, however, increases the cardiovascular risk. Instrumental treatment of resistant hypertension is currently testing two major fields. One is the stimulation of baroreceptors in the carotid sinus and the other is radiofrequency ablation of sympathetic nerve fibers around renal arteries to reduce blood pressure in drug resistant hypertension.
No takes yet. Share an insight, caveat, or question.
Simonyi et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: